These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 6299843)
1. Immune responses to DNA free herpes simplex proteins in man. Cappel R; Sprecher S; de Cuyper F Dev Biol Stand; 1982; 52():345-50. PubMed ID: 6299843 [TBL] [Abstract][Full Text] [Related]
2. [Herpes simplex virus vaccine studies: from past to present]. Us D Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702 [TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of a herpes simplex subunit vaccine. Cappel R; Sprecher S; De Cuyper F; De Braekeleer J J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419 [TBL] [Abstract][Full Text] [Related]
4. Immune response to a DNA free herpes simplex vaccine in man. Cappel R; Sprecher S; Rickaert F; de Cuyper F Arch Virol; 1982; 73(1):61-7. PubMed ID: 6289778 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329 [TBL] [Abstract][Full Text] [Related]
8. Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis. Skinner GR; Woodman C; Hartley C; Buchan A; Fuller A; Wiblin C; Wilkins G; Melling J Dev Biol Stand; 1982; 52():333-44. PubMed ID: 6299842 [TBL] [Abstract][Full Text] [Related]
9. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses. Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455 [TBL] [Abstract][Full Text] [Related]
10. Antibody and cell-mediated immunity to a DNA free herpes simplex subunit vaccine. Cappel R; de Cuyper F; de Braekeleer J Dev Biol Stand; 1979; 43():381-5. PubMed ID: 230114 [TBL] [Abstract][Full Text] [Related]
11. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease. Jones CA; Cunningham AL Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632 [TBL] [Abstract][Full Text] [Related]
12. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1. Morrison LA; Knipe DM Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723 [TBL] [Abstract][Full Text] [Related]
13. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Da Costa XJ; Morrison LA; Knipe DM Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897 [TBL] [Abstract][Full Text] [Related]
14. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections. Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602 [TBL] [Abstract][Full Text] [Related]
15. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102 [TBL] [Abstract][Full Text] [Related]
16. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting. Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection. Ghiasi H; Cai S; Nesburn AB; Wechsler SL Virology; 1996 Oct; 224(1):330-3. PubMed ID: 8862430 [TBL] [Abstract][Full Text] [Related]
19. Prospects for control of herpes simplex virus disease through immunization. Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations. Cappel R Arch Virol; 1976; 52(1-2):29-35. PubMed ID: 187150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]